Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Shuang DAI"'
Publikováno v:
European Urology Open Science, Vol 68, Iss , Pp 48-60 (2024)
Background and objective: Stress urinary incontinence (SUI) in women is a common condition that affects middle-aged and elderly women. Currently, there are still many limitations in the epidemiological research on SUI. This study aims to address the
Externí odkaz:
https://doaj.org/article/5cac936911c943babb1801112a6e078a
Autor:
Xiaocan Liu, Danfeng Luo, Shuang Dai, Yanting Cai, Tianyan Chen, Xingfu Bao, Min Hu, Zhen Liu
Publikováno v:
Advanced Science, Vol 11, Iss 41, Pp n/a-n/a (2024)
Abstract With the rapid emergence of antibiotic‐resistant pathogens, nanomaterial‐assisted catalytic sterilization has been well developed to combat pathogenic bacteria by elevating the level of reactive oxygen species including hydroxyl radical
Externí odkaz:
https://doaj.org/article/8c392bf4c9634a47bab12ec20cf3b314
Autor:
Tao Wang, Dan Song, Xuejuan Li, Yu Luo, Dianqiang Yang, Xiaoyan Liu, Xiaodan Kong, Yida Xing, Shulin Bi, Yan Zhang, Tao Hu, Yunyun Zhang, Shuang Dai, Zhiqiang Shao, Dahan Chen, Jinpao Hou, Esteban Ballestar, Jianchun Cai, Feng Zheng, James Y. Yang
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-24 (2024)
Abstract Endosomal single-stranded RNA-sensing Toll-like receptor-7/8 (TLR7/8) plays a pivotal role in inflammation and immune responses and autoimmune diseases. However, the mechanisms underlying the initiation of the TLR7/8-mediated autoimmune sign
Externí odkaz:
https://doaj.org/article/872383c0e3444fc1b70aaaddabc2e38c
Publikováno v:
Genes and Diseases, Vol 11, Iss 2, Pp 807-818 (2024)
Immune checkpoint inhibitors (ICIs) are monoclonal antibody antagonists, which can block cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death-1/ligand-1 (PD-1/PD-L1) pathways, and other molecules exploited by tumor cells to evade T cell-mediat
Externí odkaz:
https://doaj.org/article/ffeb053e24d440bfa4a1a3d9d78c654a
Publikováno v:
Pharmacological Research, Vol 206, Iss , Pp 107304- (2024)
Over the last decade, epidermal growth factor receptor (EGFR)-targeted therapies have transformed the treatment landscape for patients with advanced solid tumors. Despite these advances, resistance to anti-EGFR therapies is still a significant clinic
Externí odkaz:
https://doaj.org/article/f602e200b1e64c9eb7d38521b5d08eb2
Publikováno v:
Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)
Abstract Background The combination of dual‐targeted human epidermal growth factor receptor 2 (HER2) therapy and chemotherapy is the standard first‐line regimen for recurrent/metastatic breast cancer (mBC). However, the toxicity of such combinati
Externí odkaz:
https://doaj.org/article/2dc5e57a60a34892b8fce4895f71aa4a
Publikováno v:
Shipin gongye ke-ji, Vol 45, Iss 1, Pp 9-17 (2024)
As one of the main active ingredients of garlic, garlic polysaccharide has many biological activities, such as enhancing immunity, antibacterial, antiviral, antioxidant, hepatoprotective, hypolipidemic, hypoglycemic, etc., and has a broad application
Externí odkaz:
https://doaj.org/article/92ac595f7dc74638af8c8af042689c8c
Autor:
Longhao Zhang, Shuang Dai, Yufei Chen, Tingting Jin, Wei Li, Wen Wang, Jian Pu, Peng Jia, Li Zhao, Xin Sun
Publikováno v:
iScience, Vol 27, Iss 4, Pp 109240- (2024)
Summary: Obesity and overweight are significant global health issues, and numerous obesity intervention studies have been conducted. Summarizing current knowledge of interventions aims to inform researchers and policymakers to keep up-to-date with th
Externí odkaz:
https://doaj.org/article/d525857fa3334109b88b2b18af40fb03
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e23929- (2024)
Background: Bispecific antibody (BsAb)-based cancer immunotherapy has provided new avenues for the treatment of various malignancies. The approval of Blinatumomab has encouraged further investigation into these treatments, and a series of preclinical
Externí odkaz:
https://doaj.org/article/491ca01a513b4b4ba9249fc80e120c10
Autor:
Chao Wang, Yi Luo, Tianhang Zhai, Weifeng Huang, Shuang Dai, Shaogang Peng, Andy Tsun, Xiaoniu Miao, Liandi Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/5df9ef5fbac9433badca5ee537f90762